2.40
price up icon0.84%   0.02
pre-market  Vorhandelsmarkt:  2.46   0.06   +2.50%
loading
Schlusskurs vom Vortag:
$2.38
Offen:
$2.4
24-Stunden-Volumen:
1.12M
Relative Volume:
0.46
Marktkapitalisierung:
$56.60M
Einnahmen:
$155.00K
Nettoeinkommen (Verlust:
$-30.01M
KGV:
-1.4371
EPS:
-1.67
Netto-Cashflow:
$-11.98M
1W Leistung:
+15.94%
1M Leistung:
-62.38%
6M Leistung:
-68.71%
1J Leistung:
-71.90%
1-Tages-Spanne:
Value
$2.31
$2.44
1-Wochen-Bereich:
Value
$2.05
$2.48
52-Wochen-Spanne:
Value
$1.89
$11.64

Inmune Bio Inc Stock (INMB) Company Profile

Name
Firmenname
Inmune Bio Inc
Name
Telefon
(858) 964-3720
Name
Adresse
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Name
Mitarbeiter
13
Name
Twitter
@INmuneBio
Name
Nächster Verdiensttermin
2025-05-02
Name
Neueste SEC-Einreichungen
Name
INMB's Discussions on Twitter

Vergleichen Sie INMB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
INMB
Inmune Bio Inc
2.40 56.39M 155.00K -30.01M -11.98M -1.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Inmune Bio Inc Stock (INMB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-01 Herabstufung BTIG Research Buy → Neutral
2025-07-01 Herabstufung Scotiabank Sector Outperform → Sector Underperform
2025-01-28 Eingeleitet Rodman & Renshaw Buy
2024-10-21 Eingeleitet Alliance Global Partners Buy
2024-09-27 Eingeleitet Raymond James Outperform
2024-08-22 Eingeleitet Scotiabank Sector Outperform
2023-06-01 Eingeleitet Robert W. Baird Outperform
2022-05-24 Herabstufung B. Riley Securities Buy → Neutral
2021-07-07 Bestätigt Maxim Group Buy
2021-04-21 Eingeleitet B. Riley Securities Buy
2021-01-22 Bestätigt Maxim Group Buy
2020-09-01 Eingeleitet BTIG Research Buy
2020-07-15 Bestätigt H.C. Wainwright Buy
Alle ansehen

Inmune Bio Inc Aktie (INMB) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about INmune Bio Inc. stockExceptional stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

When (INMB) Moves Investors should Listen - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 22, 2025

INmune Bio Inc. Stock Analysis and ForecastUnbelievable profit margins - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives INmune Bio Inc. stock priceRapid wealth accumulation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Is INmune Bio Inc. a good long term investmentRapid wealth accumulation - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

Is INmune Bio Inc. stock overhyped or has real potentialFree Stock Selection with 300% Return - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

Why INmune Bio Inc. stock attracts strong analyst attentionInsider Strategy Insight - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How INmune Bio Inc. stock performs during market volatilityCapital Growth Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Cambridge Investment Research Advisors Inc. Makes New $180,000 Investment in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

Jul 15, 2025
pulisher
Jul 15, 2025

What makes INmune Bio Inc. stock price move sharplyTop Momentum Stock Pick - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

INmune Bio Shares Collapse After Mixed Results from Alzheimer’s Drug Trial - MSN

Jul 12, 2025
pulisher
Jul 12, 2025

Where are the Opportunities in (INMB) - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 07, 2025

INmune Bio shares slide after Phase II Alzheimer’s trial misses endpoints - MSN

Jul 07, 2025
pulisher
Jul 06, 2025

INmune Bio reverses early gains after stock offering - MSN

Jul 06, 2025
pulisher
Jul 06, 2025

INmune Bio surges ahead of mid-stage trial readout for Alzheimer’s drug - MSN

Jul 06, 2025
pulisher
Jul 05, 2025

INmune Bio's Alzheimer's drug misses mid-stage goal, shares sink to record low - MSN

Jul 05, 2025
pulisher
Jul 04, 2025

'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday - Benzinga

Jul 04, 2025
pulisher
Jul 03, 2025

INmune Bio's Alzheimer's drug falls short of mid-stage study goal, shares tumble - MSN

Jul 03, 2025
pulisher
Jul 02, 2025

XPro™'s Subgroup Success: A Silver Lining in INmune Bio's Alzheimer's Setback - AInvest

Jul 02, 2025
pulisher
Jul 02, 2025

INmune Bio's $19M Funding: A Lifeline or a Launchpad for Breakthroughs? - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

INmune Bio Stock Slumps After Alzheimer’s Drug Falls Short In Mid-Stage Trial - MSN

Jul 01, 2025
pulisher
Jul 01, 2025

(INMB) Proactive Strategies - news.stocktradersdaily.com

Jul 01, 2025
pulisher
Jul 01, 2025

INmune Bio Shares Fall After Downgrade From BTIG Research - MarketScreener

Jul 01, 2025
pulisher
Jul 01, 2025

INmune Bio Shares Plunge After Alzheimer's Trial Misses Target - Finimize

Jul 01, 2025
pulisher
Jul 01, 2025

INmune Bio (INMB) Faces Significant Downgrade by Scotiabank | INMB Stock News - GuruFocus

Jul 01, 2025
pulisher
Jul 01, 2025

A Drug-Trial Stock Sale - Bloomberg

Jul 01, 2025
pulisher
Jun 30, 2025

INmune Bio stock downgraded by Raymond James after Alzheimer’s trial miss - Investing.com Australia

Jun 30, 2025
pulisher
Jun 30, 2025

Clinical-Stage Biotech INmune Bio Secures $19M Through Strategic Share Offering - Stock Titan

Jun 30, 2025
pulisher
Jun 30, 2025

Raymond James Downgrades INmune Bio to Market Perform From Outperform; Shares Fall - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Inmune Bio’s Phase 2 Trial Shows Promise in Alzheimer’s - TipRanks

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio shares tumble as Alzheimer’s drug falls short in mid-stage trial - Proactive Investors

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio's XPro: A Missed Milestone or a Hidden Gem in Alzheimer's Drug Development? - AInvest

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio Stock Slumps After Alzheimer’s Drug Falls Short In Mid-Stage Trial By Stocktwits - Investing.com India

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio’s Stock Tanks: Worth Considering? - timothysykes.com

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio’s Alzheimer’s drug shows benefit in inflammatory subset - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio’s Alzheimer’s drug shows benefit in inflammatory subset By Investing.com - Investing.com UK

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio Reports Key Findings from Phase 2 MINDFuL Trial of XPro™ in Early Alzheimer’s Disease - The Manila Times

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio stock plummets after mixed Phase 2 Alzheimer’s trial results By Investing.com - Investing.com South Africa

Jun 30, 2025
pulisher
Jun 29, 2025

Will INmune Bio Succeed In The Alzheimer's Trial Of XPro? Data To Be Shared June 30, 2025 - Nasdaq

Jun 29, 2025
pulisher
Jun 28, 2025

INmune Bio's $19M Financing: A Strategic Move to Fuel Alzheimer's Catalyst and Build Investor Confidence - AInvest

Jun 28, 2025
pulisher
Jun 27, 2025

INmune Bio (INMB) Shares Drop 11% Following Equity Offering Announcement - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

INmune Bio (INMB) Initiates $19M Direct Stock Offering | INMB Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

INmune Bio, Inc. Announces Approximately $19 Million Registered - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

INmune Bio (INMB) Surges 61% on Anticipation of Alzheimer's Drug Data - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

INmune Bio (INMB) Plunges 27.68% Amid Equity Offering - AInvest

Jun 27, 2025

Finanzdaten der Inmune Bio Inc-Aktie (INMB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):